Lexaria Bioscience Corp LEXX

Alternate Symbol(s): LEXXW

Healthcare

Lexaria Bioscience Corp. is a Canada-based biotechnology company. The Company is engaged in pursuing the enhancement of the bioavailability of a diverse and a range of active pharmaceutical ingredients (API) using DehydraTECH, its patented proprietary drug delivery technology. The Company’s patented drug delivery technology, DehydraTECH, is designed to improve the way active molecules enter the bloodstream upon oral ingestion. DehydraTECH has also demonstrated enhanced delivery of certain active molecules into brain tissue. The Company has also developed DehydraTECH formulations for other applications demonstrating bio-absorption when administered intraorally and topically. It operates through two segments: Intellectual Property and Products. It also operates a licensed in-house research laboratory and holds an intellectual property portfolio with 35 patents granted and many patents pending worldwide. Its subsidiaries include Lexaria CanPharm ULC, and Lexaria CanPharm Holdings Corp.

NDAQ:LEXX - Post by User

Lexaria Bioscience Corp > I have demanded to do a 2 for 1 dividend

<< Previous

Bullboard Posts

Next >>

Comment by SkyLight8on Nov 23, 2021 8:28am

63 Views

Post# 34156133

RE:RE:I have demanded to do a 2 for 1 dividend

LOL you dont know what your talking about revenues are growing and current cash postion 2023 2nd quarter

add 11 million worth warrant when we get to 15 should get at least 2 inds to phase 1

each ind apprved is worth 80 million

at 160 million cap sure feed more scum on wallstreet

<< Previous

Bullboard Posts

Next >>

Visionstate set to leverage success in the U.S. market